Amebic encephalitis and meningoencephalitis: an update on epidemiology, diagnostic methods, and treatment
- PMID: 37093056
- PMCID: PMC10798061
- DOI: 10.1097/QCO.0000000000000923
Amebic encephalitis and meningoencephalitis: an update on epidemiology, diagnostic methods, and treatment
Abstract
Purpose of review: Free-living amebae (FLA) including Naegleria fowleri , Balamuthia mandrillaris , and Acanthamoeba species can cause rare, yet severe infections that are nearly always fatal. This review describes recent developments in epidemiology, diagnosis, and treatment of amebic meningoencephalitis.
Recent findings: Despite similarities among the three pathogenic FLA, there are notable variations in disease presentations, routes of transmission, populations at risk, and outcomes for each. Recently, molecular diagnostic tools have been used to diagnose a greater number of FLA infections. Treatment regimens for FLA have historically relied on survivor reports; more data is needed about novel treatments, including nitroxoline.
Summary: Research to identify new drugs and guide treatment regimens for amebic meningoencephalitis is lacking. However, improved diagnostic capabilities may lead to earlier diagnoses, allowing earlier treatment initiation and improved outcomes. Public health practitioners should continue to prioritize increasing awareness and providing education to clinicians, laboratorians, and the public about amebic infections.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest
There are no conflicts of interest.
Similar articles
-
[Amebic meningoencephalitis].Brain Nerve. 2009 Feb;61(2):115-21. Brain Nerve. 2009. PMID: 19235460 Review. Japanese.
-
Investigational drug available directly from CDC for the treatment of infections with free-living amebae.MMWR Morb Mortal Wkly Rep. 2013 Aug 23;62(33):666. MMWR Morb Mortal Wkly Rep. 2013. PMID: 23965830 Free PMC article.
-
Challenges and Strategies in Managing Naegleria fowleri-Associated Primary Amoebic Meningoencephalitis in Pakistan: A Case Report.Acta Parasitol. 2025 Jul 7;70(4):150. doi: 10.1007/s11686-025-01091-2. Acta Parasitol. 2025. PMID: 40622499
-
Innovative Methodology in the Discovery of Novel Drug Targets in the Free-Living Amoebae.Curr Drug Targets. 2019;20(1):60-69. doi: 10.2174/1389450119666180426100452. Curr Drug Targets. 2019. PMID: 29697029 Review.
-
Multiplex Real-Time Polymerase Chain Reaction Assay To Detect Acanthamoeba spp., Vermamoeba vermiformis, Naegleria fowleri, and Balamuthia mandrillaris in Different Water Sources.Am J Trop Med Hyg. 2024 Aug 6;111(4):785-790. doi: 10.4269/ajtmh.24-0028. Print 2024 Oct 2. Am J Trop Med Hyg. 2024. PMID: 39106847
Cited by
-
Environmentally derived Balamuthia mandrillaris contains endosymbiotic bacteria.Parasitol Res. 2025 Jun 2;124(6):57. doi: 10.1007/s00436-025-08505-0. Parasitol Res. 2025. PMID: 40455119 Free PMC article.
-
Secreted small RNAs of Naegleria fowleri are biomarkers for diagnosis of primary amoebic meningoencephalitis.bioRxiv [Preprint]. 2025 May 14:2025.01.11.632551. doi: 10.1101/2025.01.11.632551. bioRxiv. 2025. PMID: 39868105 Free PMC article. Preprint.
-
Fatal amoebic meningoencephalitis caused by Balamuthia mandrillaris in Pongo pygmaeus and first case report in Pan troglodytes verus.Front Vet Sci. 2025 Mar 19;12:1534378. doi: 10.3389/fvets.2025.1534378. eCollection 2025. Front Vet Sci. 2025. PMID: 40177675 Free PMC article.
-
Challenges and advances in the medical treatment of granulomatous amebic encephalitis.Ther Adv Infect Dis. 2024 Feb 2;11:20499361241228340. doi: 10.1177/20499361241228340. eCollection 2024 Jan-Dec. Ther Adv Infect Dis. 2024. PMID: 38312848 Free PMC article. Review.
-
Effect of Cinnamaldehyde and Its Nanoemulsion on Acanthamoeba castellanii Cysts and Trophozoites.Acta Parasitol. 2025 Jan 3;70(1):1. doi: 10.1007/s11686-024-00938-4. Acta Parasitol. 2025. PMID: 39747700
References
-
- Centers for Disease Control and Prevention. Free living amebic infections 2019. Available at: https://www.cdc.gov/dpdx/freelivingamebic/index.html. [Accessed 12 January 2023]
-
- Centers for Disease Control and Prevention. Naegleria fowleri - primary amebic meningoencephalitis (PAM) - sources of infection & risk factors 2023. Available at: https://www.cdc.gov/parasites/naegleria/infection-sources.html. [Accessed 10 February 2023]
-
- Haston JC, O’Laughlin K, Matteson K, et al. The epidemiology and clinical features of non-keratitis Acanthamoeba infections in the United States, 1956–2020. Open Forum Infect Dis 2023; 10:ofac682. - PMC - PubMed
-
A review of all invasive Acanthamoeba cases in the United States, describing epidemiologic trends and clinical features.
-
- Centers for Disease Control and Prevention. Naegleria fowleri - primary amebic meningoencephalitis (PAM) - Treatment 2022. Available at: https://www.cdc.gov/parasites/naegleria/treatment-hcp.html.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials